Cargando…
Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors
We introduce a stochastic branching process model of diversity in recurrent tumors whose growth is driven by drug resistance. Here, an initially declining population can escape certain extinction via the production of mutants whose fitness is drawn at random from a mutational fitness landscape. Usin...
Autores principales: | Foo, Jasmine, Leder, Kevin, Mumenthaler, Shannon M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567471/ https://www.ncbi.nlm.nih.gov/pubmed/23396647 http://dx.doi.org/10.1111/eva.12019 |
Ejemplares similares
-
Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors
por: Lindsay, Danika, et al.
Publicado: (2016) -
Evolutionary Modeling
of Combination Treatment Strategies To Overcome Resistance to Tyrosine
Kinase Inhibitors in Non-Small Cell Lung Cancer
por: Mumenthaler, Shannon M., et al.
Publicado: (2011) -
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells
por: Mumenthaler, Shannon M, et al.
Publicado: (2015) -
To rebound or not to rebound
por: Stahl, Bethany A, et al.
Publicado: (2017) -
Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D
Organoids to Evaluate Tumor Cell Growth Dynamics and Drug
Response
por: Kim, Seungil, et al.
Publicado: (2020)